Syndax Pharmaceuticals (SNDX) Short Interest Ratio & Short Volume $17.01 +0.21 (+1.25%) (As of 05:35 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Syndax Pharmaceuticals Short Interest DataSyndax Pharmaceuticals (SNDX) has a short interest of 10.60 million shares. This marks a -0.56% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.7, indicating that it would take 7.7 days of the average trading volume of 1.17 million shares to cover all short positions.Current Short Interest10,600,000 sharesPrevious Short Interest10,660,000 sharesChange Vs. Previous Month-0.56%Dollar Volume Sold Short$167.80 millionShort Interest Ratio7.7 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares85,360,000 sharesPercentage of Shares Shorted12.42%Today's Trading Volume1,477,544 sharesAverage Trading Volume1,170,608 sharesToday's Volume Vs. Average126% Short Selling Syndax Pharmaceuticals? Sign up to receive the latest short interest report for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNDX Short Interest Over TimeSNDX Days to Cover Over TimeSNDX Percentage of Float Shorted Over Time Ad Weiss RatingsUrgent warning about your moneyThe stock market is booming … And Bitcoin just hiked through the roof. But don't get fooled by the "good news" …We see dark clouds forming on the horizon … Syndax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/202410,600,000 shares $167.80 million -0.6%N/A7.7 $15.83 10/31/202410,660,000 shares $201.05 million +1.4%N/A11.2 $18.86 10/15/202410,510,000 shares $207.57 million +4.3%N/A10.7 $19.75 9/30/202410,080,000 shares $194.04 million +4.2%N/A10 $19.25 9/15/20249,670,000 shares $184.89 million +1.9%N/A9.2 $19.12 8/31/20249,490,000 shares $195.02 million +0.6%N/A9 $20.55 Get the Latest News and Ratings for SNDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/20249,430,000 shares $188.22 million +9.8%N/A8.8 $19.96 7/31/20248,590,000 shares $194.99 million +0.8%N/A7.8 $22.70 7/15/20248,520,000 shares $207.72 million +2.2%N/A8.3 $24.38 6/30/20248,340,000 shares $171.22 million -15.9%N/A8.1 $20.53 6/15/20249,920,000 shares $199.49 million +2.8%N/A9.8 $20.11 5/31/20249,650,000 shares $185.96 million -3.8%N/A9.1 $19.27 5/15/202410,030,000 shares $220.06 million -0.8%N/A9.6 $21.94 4/30/202410,110,000 shares $213.62 million +5.3%N/A9.4 $21.13 4/15/20249,600,000 shares $207.55 million -0.2%N/A8.3 $21.62 3/31/20249,620,000 shares $228.96 million +15.5%N/A8.2 $23.80 3/15/20248,330,000 shares $195.92 million -8.4%N/A6.9 $23.52 2/29/20249,090,000 shares $213.07 million +5.7%N/A6.1 $23.44 2/15/20248,600,000 shares $194.96 million -1.0%N/A5.8 $22.67 1/31/20248,690,000 shares $178.06 million No ChangeN/A5.8 $20.49 1/15/20248,690,000 shares $193.27 million +3.7%N/A5.4 $22.24 12/31/20238,380,000 shares $181.09 million -19.0%N/A4.7 $21.61 12/15/202310,340,000 shares $214.76 million +1.1%N/A4.8 $20.77 11/30/202310,230,000 shares $170.28 million -3.7%N/A5.4 $16.65 11/15/202310,620,000 shares $159.94 million +6.4%N/A6.2 $15.06 10/31/20239,980,000 shares $140.52 million +17.4%N/A6.1 $14.08 10/15/20238,500,000 shares $101.92 million +12.1%N/A5.7 $11.99 9/30/20237,580,000 shares $110.06 million -0.1%N/A6 $14.52 9/15/20237,590,000 shares $131.76 million +9.1%N/A9.8 $17.36 8/31/20236,960,000 shares $128.83 million -2.8%N/A8.8 $18.51 8/15/20237,160,000 shares $132.03 million +7.7%N/A8.4 $18.44 7/31/20236,650,000 shares $141.78 million +12.1%N/A7.4 $21.32 7/15/20235,930,000 shares $125.42 million +3.3%N/A6.8 $21.15 6/30/20235,740,000 shares $120.14 million +2.5%N/A6.5 $20.93 6/15/20235,600,000 shares $119.45 million -10.0%N/A5.9 $21.33 5/31/20236,220,000 shares $124.21 million -2.7%N/A6.7 $19.97 5/15/20236,390,000 shares $135.15 million -2.0%N/A7.4 $21.15 4/30/20236,520,000 shares $133.99 million -5.2%N/A7.9 $20.55 4/15/20236,880,000 shares $137.60 million -9.8%N/A8.6 $20.00 3/31/20237,630,000 shares $161.15 million +12.4%N/A9.5 $21.12Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. 3/15/20236,790,000 shares $151.42 million +13.4%N/A8.9 $22.30 2/28/20235,990,000 shares $151.85 million +8.5%N/A7 $25.35 2/15/20235,520,000 shares $143.46 million +0.6%N/A6.8 $25.99 1/31/20235,490,000 shares $157.56 million +0.6%N/A6.5 $28.70 1/15/20235,460,000 shares $143.65 million -14.3%N/A6.4 $26.31 12/30/20226,370,000 shares $162.12 million +22.5%N/A7.3 $25.45 12/15/20225,200,000 shares $125.84 million +17.7%N/A6.1 $24.20 11/30/20224,420,000 shares $105.90 million +5.7%N/A5.8 $23.96 11/15/20224,180,000 shares $91.46 million +2.7%N/A6 $21.88 10/31/20224,070,000 shares $93.45 million -9.2%N/A5.9 $22.96 10/15/20224,480,000 shares $105.41 million +0.9%9.4%6.7 $23.53 9/30/20224,440,000 shares $106.69 million -3.5%9.3%6.7 $24.03 9/15/20224,600,000 shares $113.02 million No Change9.6%7.2 $24.57 8/31/20224,600,000 shares $108.61 million +0.4%9.7%7 $23.61 8/15/20224,580,000 shares $113.31 million +5.1%9.6%7.1 $24.74 7/31/20224,360,000 shares $88.81 million +2.6%9.2%6.6 $20.37 7/15/20224,250,000 shares $80.92 million -24.8%9.2%6.8 $19.04 6/30/20225,650,000 shares $108.71 million -4.2%12.3%9.6 $19.24 6/15/20225,900,000 shares $95.76 million -0.7%12.8%10 $16.23 5/31/20225,940,000 shares $98.01 million -6.5%13.0%10.4 $16.50 5/15/20226,350,000 shares $89.60 million -1.6%13.9%10.9 $14.11 4/30/20226,450,000 shares $108.17 million +5.9%14.3%11.5 $16.77 4/15/20226,090,000 shares $110.47 million +9.1%13.5%11.1 $18.14 3/31/20225,580,000 shares $96.98 million -9.6%12.3%10.1 $17.38 3/15/20226,170,000 shares $99.21 million +18.9%13.8%11.6 $16.08 2/28/20225,190,000 shares $80.91 million +5.3%12.2%8.7 $15.59 2/15/20224,930,000 shares $81.69 million +17.1%11.6%8.7 $16.57 1/31/20224,210,000 shares $68.79 million +25.3%10.0%7.7 $16.34 1/15/20223,360,000 shares $60.78 million No Change7.5%5.8 $18.09 12/31/20213,360,000 shares $73.55 million -5.4%N/A6 $21.89 12/15/20213,550,000 shares $67.34 million +12.0%8.0%5.8 $18.97 11/30/20213,170,000 shares $50.62 million -6.8%7.4%5.8 $15.97 11/15/20213,400,000 shares $60.83 million -45.8%8.0%6.3 $17.89 10/29/20216,270,000 shares $121.95 million -1.0%14.6%11.6 $19.45 10/15/20216,330,000 shares $117.67 million -9.1%14.7%13.1 $18.59 9/30/20216,960,000 shares $133.01 million -11.0%16.2%13.8 $19.11 9/15/20217,820,000 shares $151.40 million -5.2%18.2%15.7 $19.36 8/31/20218,250,000 shares $144.29 million +2.7%19.2%17.9 $17.49 8/13/20218,030,000 shares $127.76 million -2.0%18.8%17.5 $15.91 7/30/20218,190,000 shares $119.41 million -5.2%19.4%16.6 $14.58 7/15/20218,640,000 shares $133.06 million +10.1%20.5%14.7 $15.40 6/30/20217,850,000 shares $134.78 million +1.7%18.6%9.8 $17.17 6/15/20217,720,000 shares $147.84 million +2.5%18.3%9.4 $19.15 5/28/20217,530,000 shares $138.33 million +3.9%17.9%8.8 $18.37 5/14/20217,250,000 shares $131.30 million -1.2%N/A7.7 $18.11 4/30/20217,340,000 shares $117.07 million +16.3%N/A7.9 $15.95 4/15/20216,310,000 shares $136.80 million -7.1%N/A7 $21.68 3/31/20216,790,000 shares $142.32 million +27.9%N/A10.1 $20.96 3/15/20215,310,000 shares $121.65 million +7.7%N/A7.4 $22.91 2/26/20214,930,000 shares $114.82 million No ChangeN/A7 $23.29Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. 2/12/20214,930,000 shares $103.83 million +2.1%N/A7.5 $21.06 1/29/20214,830,000 shares $97.32 million -10.2%N/A7.1 $20.15 1/15/20215,380,000 shares $130.63 million -2.5%N/A7.3 $24.28 12/31/20205,520,000 shares $126.13 million +15.7%N/A7.7 $22.85 12/15/20204,770,000 shares $121.06 million +5.3%N/A7 $25.38 11/30/20204,530,000 shares $103.60 million -1.5%N/A7.3 $22.87 11/15/20204,600,000 shares $96.60 million +5.0%N/A9 $21.00 10/30/20204,380,000 shares $79.02 million -4.8%N/A9.3 $18.04 10/15/20204,600,000 shares $73.42 million +2.5%N/A12.6 $15.96 9/30/20204,490,000 shares $66.27 million +23.0%N/A14.8 $14.76 9/15/20203,650,000 shares $63.80 million +1.7%N/A11.3 $17.48 8/31/20203,590,000 shares $58.55 million +1.4%N/A11.4 $16.31 8/14/20203,540,000 shares $56.04 million +3.5%N/A9.1 $15.83 7/31/20203,420,000 shares $48.26 million -4.7%N/A5.9 $14.11 7/15/20203,590,000 shares $51.91 million -6.0%N/A3.9 $14.46 6/30/20203,820,000 shares $55.24 million +18.6%N/A4.2 $14.46 6/15/20203,220,000 shares $49.91 million +11.4%N/A3.7 $15.50 5/29/20202,890,000 shares $46.82 million +28.4%11.4%3.4 $16.20 5/15/20202,250,000 shares $41.67 million +27.8%8.8%2.8 $18.52 4/30/20201,760,000 shares $31.68 million -0.6%7.8%3 $18.00 4/15/20201,770,000 shares $19.29 million -1.7%7.8%6.8 $10.90 3/31/20201,800,000 shares $21.06 million +49.1%8.0%7.1 $11.70 3/13/20201,207,200 shares $12.24 million +34.7%5.4%4.4 $10.14 2/28/2020896,300 shares $8.17 million +6.4%4.0%4.3 $9.11 2/14/2020842,100 shares $10.00 million +21.8%3.9%4.6 $11.87 1/31/2020691,300 shares $7.49 million +13.4%3.0%4.1 $10.84 1/15/2020609,700 shares $5.65 million +0.5%3.0%5.4 $9.26 12/31/2019606,500 shares $4.27 million +2.0%3.0%5 $7.04 SNDX Short Interest - Frequently Asked Questions What is Syndax Pharmaceuticals' current short interest? Short interest is the volume of Syndax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 10,600,000 shares of SNDX short. Learn More on Syndax Pharmaceuticals' current short interest. What is a good short interest ratio for Syndax Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNDX shares currently have a short interest ratio of 8.0. Learn More on Syndax Pharmaceuticals's short interest ratio. Which institutional investors are shorting Syndax Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Syndax Pharmaceuticals: Jane Street Group LLC, and Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Syndax Pharmaceuticals' short interest increasing or decreasing? Syndax Pharmaceuticals saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 10,600,000 shares, a drop of 0.6% from the previous total of 10,660,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Syndax Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Syndax Pharmaceuticals: Krystal Biotech, Inc. (12.52%), TG Therapeutics, Inc. (20.18%), Crinetics Pharmaceuticals, Inc. (7.01%), Arcellx, Inc. (10.93%), BridgeBio Pharma, Inc. (11.65%), Avidity Biosciences, Inc. (12.17%), ADMA Biologics, Inc. (6.02%), Biohaven Ltd. (7.73%), Ultragenyx Pharmaceutical Inc. (3.63%), Apellis Pharmaceuticals, Inc. (18.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Syndax Pharmaceuticals stock? Short selling SNDX is an investing strategy that aims to generate trading profit from Syndax Pharmaceuticals as its price is falling. SNDX shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Syndax Pharmaceuticals? A short squeeze for Syndax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNDX, which in turn drives the price of the stock up even further. How often is Syndax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNDX, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies KRYS Short Squeeze TGTX Short Squeeze CRNX Short Squeeze ACLX Short Squeeze BBIO Short Squeeze RNA Short Squeeze ADMA Short Squeeze BHVN Short Squeeze RARE Short Squeeze APLS Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNDX) was last updated on 12/6/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredUrgent warning about your moneyThe stock market is booming … And Bitcoin just hiked through the roof. But don't get fooled by the "good...Weiss Ratings | SponsoredElon declares war on company he co-founded!?Elon Musk is leading humanity into the new era of AI. He’s just received a fresh $6 billion in funding for ...Porter & Company | SponsoredWall Street genius says this bubble has run its course – what to doWhile the media is telling you to be excited about the stock market, Wall Street and the market's top experts ...Stansberry Research | SponsoredThis Company is Helping Brands Go Digital with Innovative Solutions.The growth of social media, e-Commerce, AI adoption and digital transformation has created an enormous window ...Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.